Characterization of Liver Cirrhosis in Patients Hospitalized at a University Hospital in Colombia
DOI:
https://doi.org/10.22516/25007440.1191Keywords:
Cirrhosis, alcoholism, liver, mortality, ascitesAbstract
Introduction: Cirrhosis is a chronic, diffuse, and irreversible liver disease that represents the final stage of various liver conditions caused by different etiologies.
Objective: To characterize patients with liver cirrhosis treated at a hospital in Boyacá.
Methodology: A retrospective, cross-sectional descriptive study was conducted, including patients over the age of 18 who were treated at the Hospital Universitario San Rafael in Tunja with a diagnosis of liver cirrhosis of any etiology between January 01, 2016, and December 31, 2021.
Results: The age range of the study population was 28 to 89 years, with men accounting for the majority (77.51%). The most frequent complications observed were ascites and hepatic encephalopathy. A total of 12.8% of patients required admission to the intensive care unit (ICU), 38.7% were classified as having decompensated disease (Child-Pugh C), and the overall mortality rate was 34.6%.
Conclusions: Cirrhosis imposes a significant financial burden on both the healthcare system and patients. The primary cause of cirrhosis in this population was alcohol consumption, a modifiable risk factor. The higher prevalence in men may be attributed to greater exposure to risk factors, such as alcohol consumption, which is common in the country. The mortality rate for this condition remains high, and given the natural course of the disease, it significantly impacts patients’ quality of life, leading to an increased number of years lost due to disability and premature death.
Downloads
References
Patel R, Mueller M. Alcoholic Liver Disease. 2022. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.
Vorobioff JD, Contreras F, Tanno F, Hernández L, Bessone F, Colombato L, et al. Latin American survey on demographic aspects of hospitalized, decompensated cirrhotic patients and the resources for their management. Ann Hepatol. 2020;19(4):396-403. https://doi.org/10.1016/j.aohep.2020.03.007
Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet. 2021;398(10308):1359-1376. https://doi.org/10.1016/S0140-6736(21)01374-X
Wilson R, Williams DM. Cirrhosis. Med Clin North Am. 2022;106(3):437-446. https://doi.org/10.1016/j.mcna.2021.12.001
Engelmann C, Clària J, Szabo G, Bosch J, Bernardi M. Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction. J Hepatol. 2021;75 Suppl 1(Suppl 1):S49-S66. https://doi.org/10.1016/j.jhep.2021.01.002
Ministerio de Salud y Protección Social de Colombia. Minsalud entrega recomendaciones frente al consumo de alcohol en festividades [Internet]. Boletín de Prensa No 1272; 2021 [consultado el 10 de febrero de 2023]. Disponible en https://www.minsalud.gov.co/Paginas/Minsalud-entrega-recomendaciones-frente-al-consumo-de-alcohol-en-festividades.aspx
Trifan A, Minea H, Rotaru A, Stanciu C, Stafie R, Stratina E, et al. Predictive Factors for the Prognosis of Alcoholic Liver Cirrhosis. Medicina (Kaunas). 2022;58(12):1859. https://doi.org/10.3390/medicina58121859
Jayathilaka R, Athukorala O, Ishara S, Silva D, Pathirage T. Alcohol brings burdens: A global and continent wise study on alcohol consumption and global burden of diseases. PLoS One. 2022;17(7):e0270998. https://doi.org/10.1371/journal.pone.0270998
Díaz LA, Idalsoaga F, Fuentes-López E, Márquez-Lomas A, Ramírez CA, Roblero JP, et al. Impact of Public Health Policies on Alcohol-Associated Liver Disease in Latin America: An Ecological Multinational Study. Hepatology. 2021;74(5):2478-2490. https://doi.org/10.1002/hep.32016
Caracterización epidemiológica y clínica de la cirrosis hepática en un centro regional del caribe colombiano: clínica general del norte. Enero 2012 a marzo 2017. Biociencias. 2018;13(1):17-30. https://doi.org/10.18041/2390-0512/bioc..1.2242
Escobar DM, Restrepo-Gutiérrez JC, Hoyos S, Navas MC. Efecto del consumo de alcohol al diagnóstico en la sobrevida de pacientes con cirrosis hepática en un Hospital Universitario de la ciudad de Medellín. Rev Colomb Gastroenterol. 2018;33(3):221-7. https://doi.org/10.22516/25007440.281
Martínez Leyva L, Palomino Besada AB, Quesada Meneses E, Oliva Rey JC, Yanes Cicard A, Descalzo García Y. Características epidemiológicas y clínicas de pacientes con cirrosis hepática. Rev Cub Med Mil. 2021;50(4):e02101479.
de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C; Baveno VII Faculty. Baveno VII - Renewing consensus in portal hypertension. J Hepatol. 2022;76(4):959-974. https://doi.org/10.1016/j.jhep.2021.12.022
D’Amico G, Pasta L, Morabito A, D’Amico M, Caltagirone M, Malizia G, et al. Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients. Aliment Pharmacol Ther. 2014;39(10):1180-93. https://doi.org/10.1111/apt.12721
Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77(5):1797-1835. https://doi.org/10.1097/HEP.0000000000000323
D’Amico G, Bernardi M, Angeli P. Towards a new definition of decompensated cirrhosis. J Hepatol. 2022;76(1):202-207. https://doi.org/10.1016/j.jhep.2021.12.023
Vélez Aguirre JD, Lepesqueur Guillén LH, Yepes Barreto IJ. La esteatohepatitis no alcohólica: una causa emergente de cirrosis en Colombia. Rev Colomb Gastroenterol. 2022;37(2):136-44. https://doi.org/10.22516/25007440.783
Prieto-Ortiz JE, Garzón Orjuela N, Sánchez-Pardo S, Prieto-Ortíz RG, Eslava Schmalbach J. Sobrevida en pacientes con cirrosis de acuerdo con su etiología. Cohorte retrospectiva. Rev Colomb Gastroenterol. 2022;37(1):24-32. https://doi.org/10.22516/25007440.703
Pereira D, María Á, Montoya G, Amador MB, Velásquez HV, Martínez JW, et al. Caracterización epidemiológica de pacientes con cirrosis en una consulta. Rev Médica Risaralda. 2014;20(5):86-94.
Departamento Administrativo Nacional de Estadística. Encuesta nacional de consumo de sustancias psicoactivas (ENCSPA) [Internet]. Bogotá: DANE; 2020 [consultado el 11 de febrero de 2023]. Disponible en: https://www.dane.gov.co/files/investigaciones/boletines/encspa/btencspa-2019.pdf
Huang DQ, Mathurin P, Cortez-Pinto H, Loomba R. Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors. Nat Rev Gastroenterol Hepatol. 2023;20(1):37-49. https://doi.org/10.1038/s41575-022-00688-6
Huang DQ, Terrault NA, Tacke F, Gluud LL, Arrese M, Bugianesi E, et al. Global epidemiology of cirrhosis - aetiology, trends and predictions. Nat Rev Gastroenterol Hepatol. 2023;20(6):388-98. https://doi.org/10.1038/s41575-023-00759-2
Kimer N, Møller S, Bendtsen F. Alcohol-related liver cirrhosis and related complications. Ugeskr Laeger. 2021;183(14):V11200850.
Facciorusso A, Antonino M, Orsitto E, Sacco R. Primary and secondary prophylaxis of spontaneous bacterial peritonitis: current state of the art. Expert Rev Gastroenterol Hepatol. 2019;13(8):751-759. https://doi.org/10.1080/17474124.2019.1644167
Kovacs TOG, Jensen DM. Varices: Esophageal, Gastric, and Rectal. Clin Liver Dis. 2019;23(4):625-642. https://doi.org/10.1016/j.cld.2019.07.005
Jakab SS, Garcia-Tsao G. Evaluation and Management of Esophageal and Gastric Varices in Patients with Cirrhosis. Clin Liver Dis. 2020;24(3):335-350. https://doi.org/10.1016/j.cld.2020.04.011
Kovacs TO, Jensen DM. Gastrointestinal hemorrhage. En: Goldman L, Schafer A (editores). Goldman-cecil medicine. 25.a edición. Saunders; 2016. p. 879-84.
Rose CF, Amodio P, Bajaj JS, Dhiman RK, Montagnese S, Taylor-Robinson SD, et al. Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy. J Hepatol. 2020;73(6):1526-1547. https://doi.org/10.1016/j.jhep.2020.07.013
Hoilat GJ, Ayas MF, Hoilat JN, Abu-Zaid A, Durer C, Durer S, et al. Polyethylene glycol versus lactulose in the treatment of hepatic encephalopathy: a systematic review and meta-analysis. BMJ Open Gastroenterol. 2021;8(1):e000648. https://doi.org/10.1136/bmjgast-2021-000648
García-Peña ÁA, Ospina D, Rico J, Fernández-Ávila DG, Muñoz-Velandia Ó, Suárez-Obando F. Prevalencia de hipertensión arterial en Colombia según información del Sistema Integral de Información de la Protección Social (SISPRO). Rev Colomb Cardiol. 2022;29(1):29-35.
Daza MT, Vega JAH, García AMV, Soler LA, Valderrama F. Situación de la enfermedad renal crónica, la hipertensión arterial y la diabetes mellitus en Colombia 2021. Colombia: Fondo Colombiano de Enfermedades de Alto Costo; 2022.
Schargrodsky H, Hernández-Hernández R, Champagne BM, Silva H, Vinueza R, Silva Ayçaguer LC, et al. CARMELA: assessment of cardiovascular risk in seven Latin American cities. Am J Med. 2008;121(1):58-65. https://doi.org/10.1016/j.amjmed.2007.08.038
Vargas-Uricoechea H, Casas-Figueroa LÁ. An Epidemiologic Analysis of Diabetes in Colombia. Ann Glob Health. 2015;81(6):742-53. https://doi.org/10.1016/j.aogh.2015.11.001
Corsi DJ, Subramanian SV, Chow CK, McKee M, Chifamba J, Dagenais G, et al. Prospective Urban Rural Epidemiology (PURE) study: Baseline characteristics of the household sample and comparative analyses with national data in 17 countries. Am Heart J. 2013;166(4):636-646.e4. https://doi.org/10.1016/j.ahj.2013.04.019
Daza MT, Vega JAH, García AMV, Soler LA, Valderrama F. Situación de la artritis reumatoide en Colombia 2021. Colombia: Fondo Colombiano de Enfermedades de Alto Costo; 2022.
Ruiz LC, Torres JM, Quemba LC, Parada LA, Vargas LJ. Factores asociados con colelitiasis en un hospital de Boyacá. Repert Med y Cirugía. 2022;31(3):251-5. https://doi.org/10.31260/RepertMedCir.01217372.1186
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Revista colombiana de Gastroenterología
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
Los autores/as ceden sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación en esta revista.
Los contenidos están protegidos bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.
